Target intelligence / Profile preview

DNA synthesis enzyme and cellular division machinery

Molecular classification
Enzyme, Protein complex, Cell cycle regulator
01

Overview

DNA synthesis enzymes and cellular division machinery comprise a multifaceted set of proteins and complexes required for accurate duplication and segregation of the genome prior to cell division. Central components include DNA polymerase, helicase, ligase, topoisomerase, primase, and accessory proteins that together form the replisome and coordination complexes at the replication fork. In eukaryotes, cell cycle progression is tightly regulated by cyclin-dependent kinases and structural proteins like cohesins and condensins. This machinery is a prime therapeutic target in cancer and infectious disease, where chemotherapeutic and antimicrobial agents disrupt replication or cell cycle processes. Because "DNA synthesis enzymes/cellular division machinery" encompasses numerous distinct targets rather than a single molecule, it is important to specify the individual component (e.g., "DNA polymerase" or "topoisomerase II") when discussing drug interactions or biomarker relevance.

Other names
DNA replication enzymesDNA replication machineryreplication fork proteinsreplisomecell cycle machinerycellular division enzymes
02

Mechanism of action

Enzyme inhibition (blocking DNA polymerases, helicases, ligases, topoisomerases); Disruption of cell cycle progression; Induction of DNA damage and replication stress

03

Biological functions

DNA replicationCell cycle progression and controlChromatid segregationDNA repair
04

Disease associations

Cancer (deregulation or mutation of division or DNA synthesis machinery promotes genomic instability)Infection (antimicrobials often target replication machinery of pathogens)Neurodegenerative disease (mutations and replication stress can contribute)Aging (defective DNA synthesis and repair mechanisms are linked to premature aging)
05

Safety considerations

Cytotoxicity due to inhibition of normal cell division, especially tissues with high turnover (bone marrow, GI tract)Genomic instability or mutagenesisOff-target effects or impact on healthy rapidly dividing cells
06

Interacting drugs

Anticancer agents: platinum compounds, topoisomerase inhibitors (etoposide, doxorubicin), antimetabolites (5-fluorouracil, cytarabine), DNA polymerase inhibitors

2 more in the full profile.

07

Biomarkers

Ki-67 (cell proliferation marker)PCNA (proliferating cell nuclear antigen; replication fork component)MCM proteins (Mini-Chromosome Maintenance complex, involved in DNA unwinding)Cyclins/CDKs (cell cycle phase markers)

Beyond the preview

Go deeper on DNA synthesis enzyme and cellular division machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA synthesis enzyme and cellular division machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call